Cross Ctry Healthcare Inc Stock Price, News & Analysis

Cross Country Healthcare (Nasdaq: CCRN) announced termination of its merger agreement with Aya Healthcare and that Aya will pay a $20 million termination fee to Cross Country effective December 4, 2025.

The parties’ HSR review was extended due to a historic 43-day government shutdown, producing an HSR waiting-period end date of December 30, 2025 which exceeded the Merger Agreement termination date of December 3, 2025. Cross Country said it could not reach an extension with Aya and therefore the deal was terminated.

Cross Country said it has no debt and plans to immediately commence share repurchases under an existing $40 million authorization, subject to market conditions.

Cross Country Healthcare (Nasdaq: CCRN) reported third quarter 2025 results for the period ended September 30, 2025.

Key metrics: Q3 revenue $250.1M (down 21% YoY, down 9% QoQ); consolidated gross margin 20.4% (flat YoY/QoQ); net loss $4.8M (loss per diluted share $0.15); adjusted EBITDA $6.5M (2.6% margin); and adjusted EPS $0.03. The company reported $99.1M cash, no debt, and $20.1M operating cash flow in Q3. Management highlighted >$400M in contract wins/renewals, 29% revenue growth in Homecare Staffing, and ongoing merger process with Aya, which remains subject to FTC review and a potential extension of the merger end date.

Cross Country Healthcare (NASDAQ: CCRN) announced its marketing team was named No. 1 Marketing Team in the Nation by the 2025 OnCon Icon Awards on October 22, 2025. The peer‑and‑community voted award recognized the team for creativity, innovation, measurable impact and leadership across healthcare, education and broader marketing fields.

The company highlighted a data‑driven, performance‑focused approach that blends data, design and storytelling, and said the team leverages emerging digital and AI technologies to drive demand generation and business growth.

Cross Country Healthcare (NASDAQ:CCRN) reported Q2 2025 financial results showing revenue of $274.1 million, down 19% year-over-year and 7% sequentially. The company posted a net loss of $6.7 million, or $(0.20) per share, with adjusted EBITDA of $7.6 million.

Key highlights include 30% year-over-year growth in Homecare Staffing and 3% growth in Physician Staffing revenue. The company maintained a strong financial position with $81.2 million in cash and no debt. The Nurse and Allied Staffing segment revenue decreased 23% to $224.3 million, while average field contract personnel declined to 7,035 FTEs.

The company's pending merger with Aya Healthcare is expected to close in Q4 2025. Due to this transaction, CCRN will not host an earnings call or provide forward-looking guidance.

Cross Country Healthcare (NASDAQ: CCRN) reported its Q1 2025 financial results, showing mixed performance across segments. Revenue decreased 23% year-over-year to $293.4 million, while the company reported a net loss of $0.5 million ($0.02 per share). Gross profit margin was 20.0%, down 40 basis points year-over-year.

Key highlights include: Homecare Staffing and Physician Staffing showed growth, with Physician Staffing revenue increasing 9% year-over-year to $51.1 million. The company maintained a strong balance sheet with $81 million cash and no debt. The Nurse and Allied Staffing segment saw revenue decline 27% to $242.3 million.

The company continues to work towards its pending merger with Aya Healthcare, expected to close in the second half of 2025. Due to this pending transaction, CCRN will not host an earnings call or provide forward-looking guidance.

Cross Country Healthcare and Florida Atlantic University's Christine E. Lynn College of Nursing have released their fourth annual "Beyond the Bedside: The State of Nursing in 2025" survey, revealing a critical situation in the nursing profession.

Key findings from 2,600 nursing professionals show:

• 65% of nurses report high stress and burnout
• Only 60% would choose nursing again
• 67% of student nurses worry about workload management
• 82% of students remain excited about their nursing future

The report identifies five crucial priorities:

• Improved staffing and recruitment
• Competitive pay and benefits
• Better work-life balance initiatives
• Enhanced leadership and communication
• Streamlined credentialing

Major stressors include short staffing, inadequate pay, lack of leadership support, and patient abuse. The study calls for immediate action to prevent losing an entire generation of healthcare professionals.

Cross Country Healthcare (CCRN) reported Q4 2024 financial results with revenue of $309.9 million, down 25% year-over-year. The company posted a net loss of $3.8 million, or $0.12 per share, compared to net income of $9.0 million in the prior year.

Q4 highlights include strong performance in non-travel businesses, with Physician Staffing revenue up 13% and continued growth in Education and Homecare segments. The company maintained a robust balance sheet with $82 million cash and no debt. In 2024, CCRN repurchased over 2.4 million shares for $36.8 million.

For full-year 2024, revenue decreased 33% to $1.3 billion, with a net loss of $14.6 million. The company secured a three-year renewal with its largest managed service program and is awaiting the closing of its pending merger with Aya Healthcare, expected in H2 2024.

Cross Country Healthcare (NASDAQ: CCRN) has secured all necessary stockholder approvals for its proposed acquisition by Aya Healthcare. The transaction is expected to complete in the second half of 2025, subject to customary closing conditions outlined in the Merger Agreement. Upon completion, Cross Country will become a private company and delist from NASDAQ. BofA Securities and Davis Polk & Wardwell LLP are serving as financial and legal advisors respectively to Cross Country.

Aya Healthcare has announced the acquisition of Cross Country Healthcare for $615 million in an all-cash transaction at $18.61 per share, representing a 67% premium to Cross Country's closing price on December 3, 2024. The merger combines complementary tech-enabled workforce solutions, expanding Aya's coverage to include Cross Country's clinical services in non-clinical settings across all 50 states.

The combined entity will offer enhanced services including travel nursing, allied health, per diem, permanent staff hiring, interim leadership, and locum tenens. Cross Country will operate as a separate brand under Aya, with John A. Martins continuing as President and CEO. The transaction is expected to close in first half of 2025, subject to stockholder and regulatory approvals.